Crossmark

The acceptability of targeted mass treatment with primaquine for local elimination of vivax malaria in a northern Myanmar township: a mixed-methods study

Crossref DOI link: https://doi.org/10.1186/s13071-021-05064-y

Published Online: 2021-10-24

Published Print: 2021-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Aung, Pyae Linn

Soe, Myat Thu

Soe, Than Naing

Oo, Thit Lwin

Aung, Poh Poh

Khin, Aung

Thi, Aung

Phuanukoonnon, Suparat

Okanurak, Kamolnetr

Cui, Liwang

Kyaw, Myat Phone

Parker, Daniel M. https://orcid.org/0000-0002-5352-7338
Funding

Funding for this research was provided by:

national institutes of health (U19AI089672)
License Information

Text and Data Mining valid from 2021-10-24

Version of Record valid from 2021-10-24
More Information

Article History

Received: 9 July 2021

Accepted: 12 October 2021

First Online: 24 October 2021

Declarations

:

: The study protocol was reviewed and approved by the Institutional Review Boards of the University of Public Health, Yangon, Myanmar (UPH-IRB: 2020/IR Research/2), and the University of South Florida, USA. Consent forms were signed by the respondents before commencing the interviews.

: Not applicable.

: The authors declare that they have no competing interests.

Document is current

Any future updates will be listed below